Indication
Alzheimer Disease
4 clinical trials
6 products
Clinical trial
A Randomized, Participant & Investigator Blinded, Placebo-Controlled Study to Evaluate the Ability of Intrathecally Administered NIO752 to Lower CSF Total Tau Synthesis in Participants With AD Measured by Stable Isotope Labelling KineticsStatus: Not yet recruiting, Estimated PCD: 2025-02-01
Product
NIO752Clinical trial
Randomized, Blinded, Sham-Controlled Trial of Acupuncture on the Progression of Mild Alzheimer's DiseaseStatus: Recruiting, Estimated PCD: 2025-12-01
Product
DonepezilClinical trial
A Clinical Study Exploring Lacosamide and Levetiracetam in Improving Cognitive in Patients With Alzheimer's Disease and EpilepsyStatus: Recruiting, Estimated PCD: 2025-12-31
Product
LacosamideProduct
LevetiracetamClinical trial
Assessment of Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for the Treatment of Patients With With Mild Cognitive Impairment (MCI) or Mild Alzheimer's Disease (AD) Undergoing Standard of Care Monoclonal Antibody (mAb) TherapyStatus: Recruiting, Estimated PCD: 2029-07-01
Product
AducanumabProduct
Lecanemab